LupusNephritis,Rheumatology,Nephrology – MashupMD

Mashup Score: 0

REGENCY: Obinutuzumab Proves Efficacy in Lupus Nephritis - 7 hour(s) ago

Use of obinutuzumab was associated with significant improvements in complete renal response rate and markers of disease activity in active lupus nephritis.

Source: www.hcplive.com

Categories: General Medicine News, General HCPs

Tweet Tweets with this article
- MDMagazine
  
  Phase 3 REGENCY trial: Obinutuzumab (Gazyva/Gazyvaro; @Roche) outperforms standard therapy in #LupusNephritis. ✅ 46.4% achieved complete renal response ✅ Improved disease markers & proteinuria ✅ Reduced renal-related events https://t.co/7UvTKX56tR #Rheumatology #Nephrology https://t.co/SYtnYcxjTM

Mashup Score: 0

REGENCY: Obinutuzumab Proves Efficacy in Lupus Nephritis - 2 day(s) ago

Use of obinutuzumab was associated with significant improvements in complete renal response rate and markers of disease activity in active lupus nephritis.

Source: www.hcplive.com

Categories: General Medicine News, General HCPs

Tweet Tweets with this article
- MDMagazine
  
  Phase 3 REGENCY trial: Obinutuzumab (Gazyva/Gazyvaro; @Roche) outperforms standard therapy in #LupusNephritis. ✅ 46.4% achieved complete renal response ✅ Improved disease markers & proteinuria ✅ Reduced renal-related events https://t.co/7UvTKX56tR #Rheumatology #Nephrology https://t.co/SYtnYcxjTM